Results 1 to 10 of about 279,747 (416)
Methicillin-resistant Staphylococcus aureus [PDF]
Nature Reviews Disease Primers, 2018 Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged, disseminated globally and become a leading cause of bacterial infections in both health-care and community settings. However, there is marked geographical variation in MRSA burden owing to several factors, including differences in local infection control practices and ...
Andie S. Lee +6 more
semanticscholar +8 more sources
Methicillin-resistant Staphylococcus aureus in Nepal
Journal of Nepal Medical Association, 2021 Staphylococcus aureus is both a frequent commensal and a leading cause of endocarditis, bacteremia, osteomyelitis and skin and soft tissue infections and device-related infections.
Lok Bahadur Shrestha +5 more
doaj +3 more sources
Methicillin resistant Staphylococcus aureus. [PDF]
West Indian Medical Journal, 2006 In the Caribbean, the typical Staphylococcus aureus (S aureus) is penicillin resistant, but susceptible to beta-lactamase stable penicillins to which methicillin belongs, first and second generation cephalosporins and beta-lactam/beta-lactam inhibitor ...
G. Saunders
semanticscholar +2 more sources
Methicillin-Resistant Staphylococcus aureus
Emerging Infectious Diseases, 2004 Methicillin-resistant Staphylococcus aureus (MRSA) is first and foremost a pathogen of healthcare settings. It is the most common pathogen associated with nosocomial infections in the United States, particularly nosocomial pneumonia and surgical site infections. It is also a frequent cause of bloodstream and skin and soft tissue infections.
Fred C. Tenover, Michele L. Pearson
doaj +4 more sources
Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus [PDF]
Journal of Kerman University of Medical Sciences, 2014 Background & Aims: Staphylococcus aureus is one of the most common pathogens in nosocomial infections. Vancomycin is the most important therapeutic drug of choice for treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA ...
Parviz Mohajeri +4 more
doaj +2 more sources
Methicillin resistance and the biofilm phenotype in Staphylococcus aureus [PDF]
Frontiers in Cellular and Infection Microbiology, 2015 Antibiotic resistance and biofilm-forming capacity contribute to the success of Staphylococcus aureus as a human pathogen in both healthcare and community settings. These virulence factors do not function independently of each other and the biofilm phenotype expressed by clinical isolates of S.
Justine K Rudkin, James P O'gara
exaly +5 more sources
Methicillin-Resistant Staphylococcus Aureus
Saudi Journal of Medicine and Medical Sciences, 2016 Abdulaziz Al-Quorain
doaj +3 more sources
Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity
Nature, 2018 Andreas Peschel +2 more
exaly +2 more sources
Survival of Staphylococcus aureus ST398 in the human nose after artificial inoculation. [PDF]
, 2012 There is evidence that MRSA ST398 of animal origin is only capable of temporarily occupying the human nose, and it is therefore, often considered a poor human colonizer.We inoculated 16 healthy human volunteers with a mixture of the human MSSA strain ...
Advances in Veterinary Medicine +12 more
core +9 more sources
Antibiotics, 2022 Introduction: Combination therapy with daptomycin plus ceftaroline to treat methicillin-resistant Staphylococcus aureus bacteremia has been reported to reduce methicillin-resistant Staphylococcus aureus bacteremia-related mortality.
Chienhsiu Huang, Ihung Chen, Lichen Lin
doaj +1 more source